In addition to our WHO web statement (in English and French) urging countries to ensure the continuity of malaria services, we have developed an online Q&A in: English; French; Spanish; Arabic; Chinese; and Russian.
that addresses the following questions:
- Should core malaria vector control interventions be maintained in view of the rapid global spread of COVID-19?
- Should WHO-recommended preventive therapies be maintained in sub-Saharan Africa?
- Are there any changes to WHO guidance with respect to malaria diagnosis and treatment?
- What additional special measures may be needed in the context of COVID-19?
- Why is WHO particularly concerned about the spread of COVID-19 in malaria-affected areas?
- What are the key considerations for countries that are working to eliminate malaria or prevent re-establishment of transmission?
- Have there been disruptions in the global supply of key malaria-related commodities as a result of the COVID-19 pandemic?
- What is WHO doing to support malaria-affected countries in the context of COVID-19?
- What is WHO’s position on the use of chloroquine and hydroxychloroquine in the context of the COVID-19 response?
We encourage you to share the web statement and Q&A widely with your networks.
All of WHO’s country and technical guidance relating to COVID-19 can be found at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance
Pedro L. Alonso MD
Global Malaria Programme